@Biomaven at least it’s better than issuing at $60. letting institutions then profit from selling it to retail at $135. which is typical in the ipo world.
@adamfeuerstein@cjkb117 let see. say cancer. take the stock down 30% don’t listen to the explanation.
pretty typical.
maybe that black box for a JAK is better still right?